Thursday, February 9, 2012 Last update: 1:33 PM
The Best of U.S. Company Technology News
Now being accepted at FreshNews.com. See our complete guidelines.
Trade Events
EpiCept Corporation
News articles for EpiCept Corporation:
Wednesday, February 8, 2012
- EpiCept to Raise $2 Million in Registered Direct OfferingRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it has entered into a definitive agreement ... read moreEpiCept to Present at the 14th Annual BIO CEO & Investor ConferenceRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that Jack Talley, President and Chief Executive Officer, ... read more
Sunday, January 22, 2012
- EpiCept Corporation Receives Finalized FDA Guidance for AmiKet™ Phase III CIPN Program and Regulatory StrategyRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that it received further encouraging guidance for the ... read more
Sunday, January 8, 2012
- EpiCept Corporation Engages SunTrust Robinson Humphrey to Advise on Strategy to Maximize AmiKet™ PotentialRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that it has engaged SunTrust Robinson Humphrey to ... read more
Thursday, January 5, 2012
- EpiCept to Present at Two Upcoming Industry ConferencesRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that Jack Talley, President and CEO, will be ... read more
Thursday, December 22, 2011
- EpiCept Corporation Receives FDA Permission to Initiate AmiKet™ Phase III Clinical DevelopmentRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that at a meeting earlier this week with ... read more
Tuesday, December 20, 2011
- EpiCept Provides Update on Ceplene® Manufacturing at Ben Venue LaboratoriesRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today provided an update on the impact of the quality ... read more
Wednesday, November 30, 2011
- EpiCept to Present at the 22nd Annual Wall Street Institutional Investor ConferenceRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that Jack Talley, President and Chief Executive Officer, ... read more
Tuesday, November 22, 2011
- EpiCept to Present at the NYSSA Biotech and Specialty Pharma ConferenceRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that Jack Talley, President and Chief Executive Officer, ... read more
Monday, November 7, 2011
- EpiCept Corporation Reports Third Quarter 2011 Operating and Financial ResultsRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced operating and financial results for the three and ... read more
Wednesday, November 2, 2011
- EpiCept to Report Third Quarter 2011 Operating and Financial Results on November 8th, 2011Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it will host a conference call to ... read more
Thursday, September 15, 2011
- EpiCept Common Stock to Begin Trading on OTCQX®, The Highest Tier of the OTC Market, on September 19, 2011Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and Nasdaq: EPCT) today announced that its common stock will begin trading on ... read more
Sunday, September 11, 2011
- EpiCept Corporation Provides U.S. Regulatory Update for Ceplene® Clinical DevelopmentRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and Nasdaq: EPCT) today announced that at a recent meeting with the U.S. ... read more
Tuesday, September 6, 2011
- EpiCept Common Stock Approved for Primary Listing on OMX Stockholm ExchangeRegulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and Nasdaq: EPCT) today announced that Nasdaq OMX Stockholm AB has approved the ... read more
Wednesday, August 31, 2011
- EpiCept to Present at Two Upcoming Industry ConferencesRegulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that Jack Talley, President and CEO, will be ... read more
Sunday, August 14, 2011
- EpiCept Corporation Reports Second Quarter 2011 Financial Results and Provides Business UpdateRegulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced operating and financial results for the three and ... read more